Second Generic Drugmaker Settles U.S. Price-Fixing Charges

(Bloomberg) -- Rising Pharmaceuticals Inc. agreed to pay more than $3 million to settle U.S. charges that it conspired to fix prices for a hypertension medicine, the second company to resolve a lon...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.